SPOTLIGHT -
Red wavelength should not be forgotten, Professor Michael Stur advises.
TEASE-3 study: Positive interim data are reported for Stargardt drug
Gildeuretinol halts Stargardt disease progression, study results indicate
Interactive vision simulator illustrates the vision loss caused by retinal diseases
The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases
Retina community mourns sudden loss of Ramin Tadayoni, MD, PhD
Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President
Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center
Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation
Hemorrhagic unilateral retinopathy: No proven aetiology for rare condition
Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages
Exonate shares results from Phase Ib/IIa trial of EXN407 eye drops for DR and DME
In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407